Evidence map›Paper›PMID 11994415›Full record

ArticleThe Journal of experimental medicine2002

Escaping high viral load exhaustion: CD8 cells with altered tetramer binding in chronic hepatitis B virus infection.

Stephanie Reignat, George J M Webster, David Brown, Graham S Ogg, Abigail King, Suranjith L Seneviratne, Geoff Dusheiko, Roger Williams, Mala K Maini, Antonio Bertoletti

Open access · bronzeAbstract read
In one paragraph

Article in The Journal of experimental medicine, 2002. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 97 papers.

0numbers the graph read from it
0cells of the map it votes in
97citing papers in PubMed
7.8field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

97 citing papers in PubMed, 216 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Regulation of CD8Cellular & molecular immunology · 2023
    Review
  7. T cells in health and disease.Signal transduction and targeted therapy · 2023
    Review
  8. Review
  9. Review
  10. Review
  11. Review
  12. Review
  13. Article
  14. Therapeutic vaccination for treatment of chronic hepatitis B.Clinical and experimental immunology · 2021
    Review
  15. Review
  16. HBsAg-specific CD8Cellular & molecular immunology · 2021
    Article
  17. Review
  18. Article
  19. Review
  20. Article

37 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 1 country.

Stephanie ReignatInstitute of Hepatology, University College London, London WC1 E6HX, United Kingdom.
George J M Webster
David Brown
Graham S Ogg
Abigail King
Suranjith L Seneviratne
Geoff Dusheiko
Roger Williams
Mala K Maini
Antonio Bertoletti
University College London · GBJohn Radcliffe Hospital · GBThe Royal Free Hospital · GB

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Deletion, anergy, and a spectrum of functional impairments can affect virus-specific CD8 cells in chronic viral infections. Here we characterize a low frequency population of CD8 cells present in chronic hepatitis B virus (HBV) infection which survive in the face of a high quantity of viral antigen. Although they do not appear to exert immunological pressure in vivo, these CD8 cells are not classically "tolerant" since they proliferate, lyse, and produce antiviral cytokines in vitro. They are characterized by altered HLA/peptide tetramer reactivity, which is not explained by TCR down-regulation or reduced functional avidity and which can be reversed with repetitive stimulation. CD8 cells with altered tetramer binding appear to have a specificity restricted to envelope antigen and not to other HBV antigens, suggesting that mechanisms of CD8 cell dysfunction are differentially regulated according to the antigenic form and presentation of individual viral antigens.

Indexed as

Viral LoadAdultAutoantibodiesCD8-Positive T-LymphocytesCell LineCytokinesDNA, ViralHepatitis B, ChronicHepatitis B Surface AntigensHepatitis B virusHistocompatibility Antigens Class IHumansImmune ToleranceImmunoglobulin MLymphocyte ActivationPolymerase Chain ReactionAutoantibodiesCytokinesDNA, ViralHepatitis B Surface AntigensHistocompatibility Antigens Class IImmunoglobulin MProtein SubunitsReceptors, Antigen, T-Cell

Identifiers

PMID11994415
PMCPMC2193712
OpenAlexW2166093525

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.